Atlas Trials

Cartesian Therapeutics

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cartesian Therapeutics

RecordFirmDate
Descartes-08 in Autoantibody Myositis (NCT07391605)Cartesian Therapeutics2026-04-28
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders (NCT07089121)Cartesian Therapeutics2026-01-14
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis (NCT06799247)Cartesian Therapeutics2025-05-06
Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma (NCT06304636)Cartesian Therapeutics2024-06-19
Descartes-08 for Patients With Systemic Lupus Erythematosus (NCT06038474)Cartesian Therapeutics2024-02-12
Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy (NCT04816526)Cartesian Therapeutics2021-12-01
Descartes-25 in Relapsed/Refractory Multiple Myeloma (NCT05113342)Cartesian Therapeutics2021-11-25
Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy (NCT04436029)Cartesian Therapeutics2021-02-24
Study of Descartes-30 in Acute Respiratory Distress Syndrome (NCT04524962)Cartesian Therapeutics2021-02-23
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) (NCT04146051)Cartesian Therapeutics2019-12-04
Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma (NCT03994705)Cartesian Therapeutics2019-08-01
Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma (NCT03448978)Cartesian Therapeutics2018-03-08

Track Cartesian Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.